BACKGROUND. Laser treatment for removal of lower extremity spider veins is
emerging as a modality of choice in patients with small spider veins, those
who have previously undergone sclerotherapy or vein stripping, and those r
efusing sclerotherapy.
OBJECTIVE. To determine clinical characteristics of patients presenting for
laser treatment of leg veins.
METHODS. The clinical characteristics of 500 patients presenting for laser
treatment of spider veins were evaluated to investigate characteristics lea
ding to their development, and to characterize the type of patients present
ing for laser treatment.
RESULTS. Patients presenting for treatment range widely in age and have had
spider veins for an average of 14 years. Both pregnancy and previous scler
otherapy were factors that contributed to the development or exacerbation o
f spider veins.
CONCLUSION. As laser treatment of spider veins improves, this modality will
play an increasing role in the management of lower extremity telangiectasi
as.